Effects of DA-9701, a novel prokinetic agent, on gastric accommodation in conscious dogs

Journal of Gastroenterology and Hepatology (Australia)

Volumn 27, Issue 4, 2012, Pages 766-772

  Kim, Eun Ran ^a   Min, Byung Hoon ^a   Lee, Sung Ok ^b   Lee, Tae Ho ^c   Son, Miwon ^c   Rhee, Poong Lyul ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Sungkyunkwan University   (South Korea)

^c Dong A Pharmaceutical Company   (South Korea)

Author keywords

DA 9701; Gastric accommodation; Postprandial gastric volume

Indexed keywords

DA 9701; PROKINETIC AGENT; SUMATRIPTAN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; BAROSTAT; CONSCIOUSNESS; CONTROLLED STUDY; DRUG EFFECT; DRUG MEGADOSE; DRUG POTENCY; FEMALE; FOOD INTAKE; LOW DRUG DOSE; MEAL; NONHUMAN; POSTPRANDIAL STATE; PRIORITY JOURNAL; STOMACH EMPTYING; STOMACH VOLUME;

EID: 84863346187     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2011.06924.x     Document Type: Article

References (30)

1. El-Serag HB, Talley NJ. Systemic review: the prevalence and clinical course of functional dyspepsia. Aliment. Pharmacol. Ther. 2004; 19: 643-54.
2. Maes BD, Ghoos YF, Hiele MI, Rutgeerts PJ. Gastric emptying rate of solids in patients with nonulcer dyspepsia. Dig. Dis. Sci. 1997; 42: 1158-62.
3. Sarnelli G, Caenepeel P, Geypens B, Janssens J, Tack J. Symptoms associated with impaired gastric emptying of solids and liquids in functional dyspepsia. Am. J. Gastroenterol. 2003; 98: 783-8.
4. Boeckxstaens GE, Hirsch DP, Kuiken SD, Heisterkamp SH, Tytgat GN. The proximal stomach and postprandial symptoms in functional dyspeptics. Am. J. Gastroenterol. 2002; 97: 40-8.
5. van den Elzen BD, Boeckxstaens GE. Review article: a critical view on impaired accommodation as therapeutic target for functional dyspepsia. Aliment. Pharmacol. Ther. 2006; 23: 1499-510.
6. Tack J, Caenepeel P, Fischler B, Piessevaux H, Janssens J. Symptoms associated with hypersensitivity to gastric distention in functional dyspepsia. Gastroenterology 2001; 121: 526-35.
7. Tack J, Lee KJ. Pathophysiology and treatment of functional dyspepsia. J. Clin. Gastroenterol. 2005; 39: S211-16.
8. Drolet B, Rousseau G, Daleau P, Cardinal R, Turgeon J. Domperidone should not be considered a no-risk alternative to cisapride in the treatment of gastrointestinal motility disorders. Circulation 2000; 102: 1883-5.
9. Flockhart DA, Desta Z, Mahal SK. Selection of drugs to treat gastro-oesophageal reflux disease: the role of drug interactions. Clin. Pharmacokinet. 2000; 39: 295-309.
10. Hallerback BI, Bommelaer G, Bredberg E etal. Dose finding study of mosapride in functional dyspepsia: a placebo-controlled, randomized study. Aliment. Pharmacol. Ther. 2002; 16: 959-67.
11. Talley NJ, Verlinden M, Snape W etal. Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trial. Aliment. Pharmacol. Ther. 2000; 14: 1653-61.
12. Lee TH, Choi JJ, Kim DH etal. Gastroprokinetic effects of DA-9701, a new prokinetic agent formulated with Pharbitis Semen and Corydalis Tuber. Phytomedicine 2008; 15: 836-43.
13. Xing JH, Chen JD. Reproducibility of gastric tone, compliance and gastric accommodation assessed with barostat in conscious dogs. Neurogastroenterol. Motil. 2005; 17: 83-8.
14. De Ponti F, Crema F, Moro E, Nardelli G, Frigo G, Crema A. Role of 5-HT1B/D receptors in canine gastric accommodation: effect of sumatriptan and 5-HT1B/D receptor antagonists. Am. J. Physiol. Gastrointest. Liver Physiol. 2003; 285: G96-104.
15. Tack J. Prokinetics and fundic relaxants in upper functional GI disorders. Curr. Opin. Pharmacol. 2008; 8: 690-6.
16. Karamanolis G, Caenepeel P, Arts J, Tack J. Determinants of symptom pattern in idiopathic severely delayed gastric emptying: gastric emptying rate or proximal stomach dysfunction? Gut 2007; 56: 29-36.
17. Chen J, Koothan T, Chen JD. Synchronized gastric electrical stimulation improves vagotomy-induced impairment in gastric accommodation via the nitrergic pathway in dogs. Am. J. Physiol. Gastrointest. Liver Physiol. 2009; 296: G310-18.
18. Galligan JJ, Vanner S. Basic and clinical pharmacology of new motility promoting agents. Neurogastroenterol. Motil. 2005; 17: 643-53.
19. Coulie B, Tack J, Sifrim D, Andrioli A, Janssens J. Role of nitric oxide in fasting gastric fundus tone and in 5-HT1 receptor-mediated relaxation of gastric fundus. Am. J. Physiol. 1999; 276: G373-7.
20. Tack J, Piessevaux H, Coulie B, Caenepeel P, Janssens J. Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterology 1998; 115: 1346-52.
21. Sarnelli G, Sifrim D, Janssens J, Tack J. Influence of sildenafil on gastric sensorimotor function in humans. Am. J. Physiol. Gastrointest. Liver Physiol. 2004; 287: G988-92.
22. Kindt S, Tack J. Impaired gastric accommodation and its role in dyspepsia. Gut 2006; 55: 1685-91.
23. Tack J, Coulie B, Wilmer A, Andrioli A, Janssens J. Influence of sumatriptan on gastric fundus tone and on the perception of gastric distension in man. Gut 2000; 46: 468-73.
24. Bisschops R, Tack J. Dysaccommodation of the stomach: therapeutic nirvana? Neurogastroenterol. Motil. 2007; 19: 85-93.
25. Boeckxstaens GE, Tytgat GN, Wajs E etal. The influence of the novel 5-HT1A agonist R137696 on the proximal stomach function in healthy volunteers. Neurogastroenterol. Motil. 2006; 18: 919-26.
26. Tack J, Van Den Elzen B, Tytgat G etal. A placebo-controlled trial of the 5-HT1A agonist R-137696 on symptoms, visceral hypersensitivity and on impaired accommodation in functional dyspepsia. Neurogastroenterol. Motil. 2009; 21: 619-26, e23-4.
27. Tack J, Broeckaert D, Coulie B, Janssens J. The influence of cisapride on gastric tone and the perception of gastric distension. Aliment. Pharmacol. Ther. 1998; 12: 761-6.
28. Wysowski DK, Bacsanyi J. Cisapride and fatal arrhythmia. N. Engl. J. Med. 1996; 335: 290-1.
29. Lee TH, Kim KH, Lee SO, Lee KR, Son M, Jin M. tetrahydroberberine, an isoquinoline alkaloid isolated from Corydalis Tuber, enhances gastrointestinal motor function. J. Pharmacol. Exp. Ther. 2011; 33: 917-24.
30. Lee TH, Son M, Kim SY. Effects of corydaline from Corydalis Tuber on gastric motor function in an animal model. Biol. Pharm. Bull. 2010; 33: 958-62.